Publications by authors named "Clara Eugenia Perez"
Article Synopsis
- The study aimed to evaluate the clinical and cost-effectiveness of therapeutic drug monitoring (TDM) for adalimumab levels in patients with rheumatic diseases compared to standard care over 18 months.
- In this non-randomized trial involving 150 patients, the intervention group (IG) showed numerically fewer flares and improved health-related quality of life (HRQoL) metrics at 3 and 6 months compared to the control group (CG).
- Although the primary endpoint regarding flare reduction wasn't met, the IG had lower direct medical costs and achieved a higher quality-adjusted life years (QALYs), indicating that TDM-based dose adjustment is both effective and cost-efficient.
Objective: To estimate prevalence and distribution of cardiovascular risk factors and Metabolic Syndrome (MS) in young individuals admitted to the National University of Colombia in Bogotá.
Methods: An analytic cross-sectional study was conducted in a sample of 249 individuals of both genders aged 15 to 20 years. A questionnaire was personally administered to collect demographic, socioeconomic, smoking, perinatal, and women's health data.
Background: Cardiovascular disease is a major cause of morbidity/mortality in non-developed countries. Reports of the effects of non-pharmacological interventions on global cardiovascular risk in Latin American adults, however, are scarce.
Objective: To compare the change in global cardiovascular risk induced by a tailored, Adult Treatment Panel-III compliant nutrition program versus the same program with addition of supervised, regular physical activity in Colombian adults.